Axe Compute Inc. (AGPU) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Axe Compute Inc. (AGPU) has a cash flow conversion efficiency ratio of -0.078x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.74 Million) by net assets ($47.72 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Axe Compute Inc. - Cash Flow Conversion Efficiency Trend (2008–2025)
This chart illustrates how Axe Compute Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read AGPU liabilities breakdown for a breakdown of total debt and financial obligations.
Axe Compute Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Axe Compute Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kothari Sugars And Chemicals Limited
NSE:KOTARISUG
|
-0.030x |
|
Adler Group SA
F:ADJ
|
0.029x |
|
Kumbi Corporation
KO:008870
|
0.059x |
|
Shui-Mu International Co Ltd
TW:8443
|
0.015x |
|
Fidelity European Values
LSE:FEV
|
0.003x |
|
Aetherium Acquisition Corp
NASDAQ:GMFI
|
N/A |
|
Mmcité a.s.
PR:MMCTE
|
N/A |
|
OD6 Metals Ltd
AU:OD6
|
-0.066x |
Annual Cash Flow Conversion Efficiency for Axe Compute Inc. (2008–2025)
The table below shows the annual cash flow conversion efficiency of Axe Compute Inc. from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see Axe Compute Inc. stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $47.72 Million | $-9.88 Million | -0.207x | -100.35% |
| 2024-12-31 | $-202.61K | $-11.96 Million | 59.008x | +3800.73% |
| 2023-12-31 | $8.27 Million | $-13.19 Million | -1.595x | -180.55% |
| 2022-12-31 | $21.77 Million | $-12.37 Million | -0.568x | -87.45% |
| 2021-12-31 | $40.27 Million | $-12.21 Million | -0.303x | +93.46% |
| 2020-12-31 | $2.64 Million | $-12.26 Million | -4.638x | -496.57% |
| 2019-12-31 | $11.23 Million | $-8.73 Million | -0.778x | +99.21% |
| 2018-12-31 | $53.47K | $-5.29 Million | -98.890x | -5869.03% |
| 2017-12-31 | $2.69 Million | $-4.46 Million | -1.657x | +65.07% |
| 2016-12-31 | $923.68K | $-4.38 Million | -4.743x | -160.55% |
| 2015-12-31 | $4.11 Million | $-7.49 Million | -1.821x | -397.87% |
| 2014-12-31 | $-5.52 Million | $-3.37 Million | 0.611x | -48.98% |
| 2013-12-31 | $-3.22 Million | $-3.86 Million | 1.198x | +234.13% |
| 2012-12-31 | $-3.30 Million | $-1.18 Million | 0.358x | -45.61% |
| 2011-12-31 | $-2.70 Million | $-1.78 Million | 0.659x | +75.84% |
| 2010-12-31 | $-2.19 Million | $-820.68K | 0.375x | -32.99% |
| 2009-12-31 | $-2.34 Million | $-1.31 Million | 0.559x | -80.78% |
| 2008-12-31 | $-309.44K | $-900.53K | 2.910x | -- |
About Axe Compute Inc.
Axe Compute Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D culture mode… Read more